23 research outputs found
Low concentrations of nitric oxide delay the differentiation of embryonic stem cells and promote their survival
Nitric oxide (NO) is an intracellular messenger in several cell systems, but its contribution to embryonic stem cell (ESC) biology has not been characterized. Exposure of ESCs to low concentrations (2–20 μM) of the NO donor diethylenetriamine NO adduct confers protection from apoptosis elicited by leukaemia inhibitory factor (LIF) withdrawal. NO blocked caspase 3 activation, PARP degradation, downregulation of the pro-apoptotic genes Casp7, Casp9, Bax and Bak1 and upregulation of the anti-apoptotic genes Bcl-2 111, Bcl-2 and Birc6. These effects were also observed in cells overexpressing eNOS. Exposure of LIF-deprived mESCs to low NO prevented the loss of expression of self-renewal genes (Oct4, Nanog and Sox2) and the SSEA marker. Moreover, NO blocked the differentiation process promoted by the absence of LIF and bFGF in mouse and human ESCs. NO treatment decreased the expression of differentiation markers, such as Brachyury, Gata6 and Gata4. Constitutive overexpression of eNOS in cells exposed to LIF deprivation maintained the expression of self-renewal markers, whereas the differentiation genes were repressed. These effects were reversed by addition of the NOS inhibitor L-NMMA. Altogether, the data suggest that low NO has a role in the regulation of ESC differentiation by delaying the entry into differentiation, arresting the loss of self-renewal markers and promoting cell survival by inhibiting apoptosis
Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes
Fibroblastic reticular cells (FRCs) and lymphatic endothelial cells (LECs) are nonhematopoietic stromal cells of lymphoid organs. They influence the migration and homeostasis of naive T cells; however, their influence on activated T cells remains undescribed. Here we report that FRCs and LECs inhibited T cell proliferation through a tightly regulated mechanism dependent on nitric oxide synthase 2 (NOS2). Expression of NOS2 and production of nitric oxide paralleled the activation of T cells and required a tripartite synergism of interferon-γ, tumor necrosis factor and direct contact with activated T cells. Notably, in vivo expression of NOS2 by FRCs and LECs regulated the size of the activated T cell pool. Our study elucidates an as-yet-unrecognized role for the lymph node stromal niche in controlling T cell responses
Nitric oxide-cyclic GMP signaling in stem cell differentiation
The nitric oxide-cyclic GMP (NO-cGMP) pathway mediates important physiological functions associated with various integrative body systems including the cardiovascular and nervous systems. Furthermore, NO regulates cell growth, survival, apoptosis, proliferation and differentiation at the cellular level. To understand the significance of the NO-cGMP pathway in development and differentiation, studies have been conducted both in developing embryos and stem cells. Manipulation of the NO-cGMP pathway by employing activators and inhibitors as pharmacological probes and/or genetic manipulation of NO signaling components has implicated the involvement of this pathway in regulation of stem cell differentiation. This review will focus on some of the work pertaining to the role of NO-cGMP in differentiation of stem cells into cells of various lineages particularly into myocardial cells and stem cell based therapy
Expression of inducible nitric oxide synthase messenger RNA, but not guanylate cyclase messenger RNA, depends on gestational age in rat myometrium
Cytoprotection by the NO-donor SNAP against ischemia/reoxygenation injury in mouse embryonic stem cell-derived cardiomyocytes
Embryonic stem cell (ESC)-derived cardiomyocytes are a promising
cell source for the screening for potential cytoprotective
molecules against ischemia/reperfusion injury, however, little
is known on their behavior in hypoxia/reoxygenation conditions.
Here we tested the cytoprotective effect of the NO-donor SNAP
and its downstream cellular pathway. Mouse ESC-derived
cardiomyocytes were subjected to 150-min simulated ischemia (SI)
followed by 120-min reoxygenation or corresponding non-ischemic
conditions. The following treatments were applied during SI or
normoxia: the NO-donor S-Nitroso-N-acetyl-D,L-penicillamine
(SNAP), the protein kinase G (PKG) inhibitor, the KATP channel
blocker glibenclamide, the particulate guanylate cyclase
activator brain type natriuretic peptide (BNP), and a non-
specific NO synthase inhibitor (N-Nitro-L-arginine, L-NNA) alone
or in different combinations. Viability of cells was assayed by
propidium iodide staining. SNAP attenuated SI-induced cell death
in a concentration-dependent manner, and this protection was
attenuated by inhibition of either PKG or KATP channels.
However, SI-induced cell death was not affected by BNP or by L-
NNA. We conclude that SNAP protects mESC-derived cardiomyocytes
against SI/R injury and that soluble guanylate-cyclase, PKG, and
KATP channels play a role in the downstream pathway of SNAP-
induced cytoprotection. The present mESC-derived cardiomyocyte-
based screening platform is a useful tool for discovery of
cytoprotective molecules